---
title: "Insmed Chief Medical Officer Martina Flammer Reports Disposal of Common Shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/275173513.md"
datetime: "2026-02-06T21:19:24.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275173513.md)
  - [en](https://longbridge.com/en/news/275173513.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275173513.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/275173513.md) | [繁體中文](https://longbridge.com/zh-HK/news/275173513.md)


# Insmed Chief Medical Officer Martina Flammer Reports Disposal of Common Shares

Martina Flammer, M.D., Chief Medical Officer of Insmed Inc., reported a disposal of common shares of Insmed Inc. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insmed Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001796960-26-000010), on February 06, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [iShares Global Healthcare ETF (IXJ.US)](https://longbridge.com/en/quote/IXJ.US.md)
- [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/en/quote/IBB.US.md)
- [VanEck Biotech ETF (BBH.US)](https://longbridge.com/en/quote/BBH.US.md)
- [Invesco Dorsey Wright Healthcare MomtETF (PTH.US)](https://longbridge.com/en/quote/PTH.US.md)
- [ProShares Ultra Nasdaq Biotechnology (BIB.US)](https://longbridge.com/en/quote/BIB.US.md)
- [State Street®HlthCrSelSectSPDR®ETF (XLV.US)](https://longbridge.com/en/quote/XLV.US.md)
- [ALPS Medical Breakthroughs ETF (SBIO.US)](https://longbridge.com/en/quote/SBIO.US.md)
- [State Street® SPDR® S&P® Biotech ETF (XBI.US)](https://longbridge.com/en/quote/XBI.US.md)
- [BNY Mellon Innovators ETF (BKIV.US)](https://longbridge.com/en/quote/BKIV.US.md)
- [Insmed Incorporated (INSM.US)](https://longbridge.com/en/quote/INSM.US.md)
- [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/en/quote/PBE.US.md)
- [iShares US Pharmaceuticals ETF (IHE.US)](https://longbridge.com/en/quote/IHE.US.md)
- [Vanguard Health Care ETF (VHT.US)](https://longbridge.com/en/quote/VHT.US.md)
- [First Trust NYSE Arca Biotech ETF (FBT.US)](https://longbridge.com/en/quote/FBT.US.md)
- [ARK Genomic Revolution ETF (ARKG.US)](https://longbridge.com/en/quote/ARKG.US.md)

## Related News & Research

- [Mirum Pharmaceuticals Executives Sell Shares](https://longbridge.com/en/news/279503772.md)
- [Structure Therapeutics Reports Strong Phase 2 Obesity Drug Results](https://longbridge.com/en/news/279269040.md)
- [NRx Pharma Says FDA Identifies No Bioequivalence Issues In Preservative-free Ketamine Application](https://longbridge.com/en/news/279426124.md)
- [Celcuity, Inc. (NASDAQ:CELC) Receives Consensus Recommendation of "Moderate Buy" from Analysts](https://longbridge.com/en/news/279226861.md)
- [Biotheryx Announces First Patient Dosed in the Dose Expansion Phase of BTX-9341-101 for the Treatment of HR+/HER2- Breast Cancer](https://longbridge.com/en/news/279596043.md)